Cytotoxicity and mode of action of the potential cytostatic drug oracin

Neoplasma

Volumn 49, Issue 3, 2002, Pages 167-171

  Miko, M ^a   Poturnajova, M ^a   Soucek, R ^a  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

Author keywords

Biosynthesis of macromolecules; Ehrlich cells; Mode of action; Oracin; Screening

Indexed keywords

ADENINE; CARBON 14; ORACIN; THYMIDINE; URIDINE; VALINE;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; EHRLICH ASCITES TUMOR; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN SYNTHESIS;

EID: 0036303080     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Multimodal action of antitumor agents on DNA: The ellipticine series
2. DNA topoisomerases: Structure, function, and mechanism
3. Regulation of lymphocyte survival by the blc-2 gene family
4. Topoisomerase-targeting antitumor drugs
5. The influence of dimethyl sulfoxide on metabolic activity of Ehrlich ascites carcinoma cells and microorganisms
6. ATP cell integrity
7. Secondary leukemias induced by topoisomerase-targeted drugs
8. Blc-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidylate stress is independent of clasical resistance pathways
9. G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin
10. Topotecan - A novel topoisomerase I inhibitor: Pharmacology and clinical experience
11. Cytotoxicity of 1-alkylperhydroazepine N-oxides and quantitative structure-activity relationships
12. In vitro cytototoxic activity of 1-alkyl-piperidine N-oxides and quantitative structure-activity relationships
13. Metabolic activity of the Ehrlich ascites cells in synthetic media and the significance of ascites serum addition
14. 9-Hydroxybenfluron: Cytostatic effects and inhibition of macromolecular biosynthesis in Ehrlich ascites and P388 murine leukemia cells
15. Oracine a novel inhibitor of topoisomerases I and II. 12th Mediter
16. New screening system for selection of anticancer drugs for treatment of human colorectal cancer
17. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents
18. Use of a radiometric system to screen for antineoplastic agents: Correlation with a human tumor cloning system
19. DNA topoisomerases